ASH 2024: Updates in the Treatment of CLL - Episode 10
Treatment Sequencing in R/R CLL: Optimizing Strategies and Clinical Insights From ASH 2024 Real-World Data
Panelists discuss how treatment sequencing in chronic lymphocytic leukemia (CLL) should be personalized based on prior therapy responses and resistance patterns, with emerging real-world data from ASH 2024 informing decisions about re-treatment with drug classes and treatment holidays, while considering factors like durability of previous responses and the timing of molecular resistance.
Video Player is loading.
Video content above is prompted by the following:
- What is your treatment sequencing approach? Is there an optimal treatment sequence?
- Please share your clinical treatment sequencing management and results from the ASH 2024 abstract P5114.
- Feel free to share any similarities or differences in practice in treatment sequencing.
- When do you consider re-treatment with the same class of drugs? When do you give patients treatment holidays?
Related Content:
